 |
FSD Pharma
HUGE
|
1.31 |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
MorphoSys AG
MOR
|
18.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.22 |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
13 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
0.68 |
- |
- |
$ 866 M |
China |
 |
Deciphera Pharmaceuticals
DCPH
|
14.1 |
- |
- |
$ 2.18 B |
USA |
 |
Genfit SA
GNFT
|
3.36 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
0.33 |
- |
-13.47 % |
$ 169 M |
France |
 |
AstraZeneca PLC
AZN
|
74.2 |
- |
- |
$ 96.9 B |
Britain |
 |
BioNTech SE
BNTX
|
91.2 |
$ 89.59 |
- |
$ 21.7 B |
Germany |
 |
Compugen Ltd.
CGEN
|
2.1 |
$ 2.22 |
- |
$ 207 M |
Israel |
 |
Coherus BioSciences
CHRS
|
1.93 |
$ 1.58 |
- |
$ 185 M |
USA |
 |
Athira Pharma
ATHA
|
0.42 |
- |
- |
$ 269 M |
USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.31 |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
21.6 |
- |
- |
$ 4.9 B |
Britain |
 |
Galera Therapeutics
GRTX
|
0.14 |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Midatech Pharma plc
MTP
|
0.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Affimed N.V.
AFMD
|
4.41 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 |
- |
- |
$ 231 M |
USA |
 |
Celyad Oncology SA
CYAD
|
0.47 |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
1.7 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Celldex Therapeutics
CLDX
|
30.7 |
$ 29.93 |
- |
$ 1.99 B |
USA |
 |
Generation Bio Co.
GBIO
|
2.77 |
- |
- |
$ 344 M |
USA |
 |
IMV
IMV
|
0.82 |
- |
- |
$ 13.1 M |
Canada |
 |
Akero Therapeutics
AKRO
|
48.4 |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
5.34 |
- |
0.23 % |
$ 488 M |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
0.96 |
$ 0.79 |
- |
$ 36.1 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 |
- |
- |
$ 7.46 M |
Israel |
 |
Esperion Therapeutics
ESPR
|
2.7 |
$ 3.13 |
- |
$ 651 M |
USA |
 |
Eton Pharmaceuticals
ETON
|
20.8 |
$ 28.9 |
- |
$ 778 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
4.9 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.4 |
- |
- |
$ 384 M |
Britain |
 |
Forte Biosciences
FBRX
|
25.9 |
$ 16.69 |
- |
$ 216 M |
USA |
 |
Gracell Biotechnologies
GRCL
|
6.04 |
- |
- |
$ 3.37 B |
China |
 |
Anika Therapeutics
ANIK
|
14.9 |
$ 14.79 |
- |
$ 212 M |
USA |
 |
Advaxis
ADXS
|
0.31 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
5.72 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
12 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
19.3 |
- |
- |
$ 867 M |
Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
3.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 |
$ 3.16 |
- |
$ 5.2 M |
Israel |
 |
Aptose Biosciences
APTO
|
3.32 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 |
$ 56.95 |
- |
$ 5.12 B |
Schweiz |
 |
Aptinyx
APTX
|
0.14 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
28.5 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Galectin Therapeutics
GALT
|
2.79 |
$ 2.38 |
- |
$ 152 M |
USA |